Refine/Revise Search
Featured Listing
Asking Price: $375,000

Semi-Passive Indoor Golf Simulator Franchise

Chicago, IL
Cook County

Become part of North America's fastest-growing indoor golf franchise—a modern, tech-driven model ideal for semi-passive owners, featuring low overhead and high-margin recurring revenue. This turnkey business is SBA approved and averages $25K–$50K in monthly revenue, with 80% coming from memberships and 20% from corporate or public bookings. No employees are needed; operations are automated. With over 85 operating locations and 178 more in stages of buildout, you can join this thriving industry with an established brand that's recognized coast to coast.Key Highlights:·         SBA Registered & Approved·         Average annual revenue per location: $500,000·         Access to over 65 TPC Courses using Full Swing technology·         Recurring revenue: 24/7 member access plus leagues, lessons, and events·         Proprietary software streamlines scheduling, billing, and facility entry·         Fully automated operations—no staff necessary·         Entry costs are low due to wholesale equipment and buildout pricing·         Nationwide scalability, proven by success in 85 open locations and 178 total units soldIdeal for investors interested in semi-passive income, entrepreneurs seeking recurring revenue and growth, golf lovers wanting to profit from their passion, and multi-unit owners looking for a low-labor, high-profit venture.

Cash Flow Not Disclosed
Revenue Not Disclosed

Asking Price: $400,000

Successful Profitable Pizza Shop

Not Disclosed, IL
Cook County

Successful Profitable Pizza Shop

Cash Flow $130,031
Revenue $1,024,355
$ Owner Financing Available

Asking Price: $325,000

Scalable Energy-Efficient Insulation Service

Chicago, IL
Cook County

Discover a compelling business opportunity in the growing insulation and energy efficiency sector. This full-service insulation contractor provides premium spray foam, fiberglass, cellulose, and other high-quality insulation solutions to a diverse clientele ranging from homeowners seeking enhanced comfort and lower utility bills to builders and commercial customers requiring large-scale projects. Utilizing cutting-edge spray foam technology and a comprehensive equipment package, the business delivers efficient installations that improve property value and indoor environments. Its expertise spans residential retrofits, new construction, and commercial projects in agriculture, medical, retail, and multi-family spaces.With strategic outreach programs targeting builders and contractors, the company cultivates long-term client relationships that generate consistent project pipelines. Someone will benefit from a business model designed for scalability, backed by advanced AI-enabled equipment that simplifies operations, shortens learning curves, and enables rapid growth. The business is positioned in a fragmented market characterized by rising demand for energy conservation and superior insulation services. Offering multiple revenue sources across residential and commercial segments, this opportunity is ideal for individuals aiming to own a thriving business in home improvement and building services.

Cash Flow $307,832
Revenue $1,710,176

Asking Price: Not Disclosed

Clinical Stage Oncology Co. for Early Cancer Detec

Chicago, IL
Cook County

The Company is a clinical-stage oncology company with a platform that combines biospectral impedance and AI/ML for point-of-care cancer detection. The lead product delivers rapid, in-procedure assessment of surgical margins—identifying the presence and location of cancer within minutes. Initial commercialization targets skin cancer, where the lead product can shorten procedures, spare healthy tissue, improve surgeon economics, and enhance outcomes. The Company has also built a compelling breast cancer dataset and plans to deploy the lead product to help dramatically reduce the ~20–25% re-surgery (re-excision) rate in partial mastectomies; the breast program is in line for non-dilutive CPRIT support.The Company has a collaboration with PHC Holdings (formerly Panasonic Healthcare; TSE:6529) to commercialize the lead product. The company anticipates FDA clearance in 2026 and profitability in 2028.Beyond skin and breast, the Company has generated promising data in lung, pancreatic, esophageal, and colon tissue. Follow-on products include a rapid biopsy-assessment device and a needle-based device leveraging the same platform.Use of Proceeds: This round will fund FDA clearance activities and the initial commercial launch of the lead product.NDA is required to receive comprehensive Confidential Information Memorandum (CIM) crafted by ProNova Partners.

Cash Flow $1,091
Revenue $9,498
$ Owner Financing Available

loading...
TOP ▲
Add Businesses and/or Franchises
To Basket For Free Information

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our cookies information for more details.